<DOC>
	<DOCNO>NCT00681746</DOCNO>
	<brief_summary>The study carry order determine relationship dose AZD6280 blood concentration AZD6280 , investigate extent AZD6280 bind GABAA receptor</brief_summary>
	<brief_title>Positron Emission Tomography ( PET ) Study With ( 11C ) Flumazenil Determine Central GABAA Receptor Occupancy AZD6280</brief_title>
	<detailed_description />
	<mesh_term>Flumazenil</mesh_term>
	<criteria>Body Mass Index ( BMI ) 1830 kg/m2 weight 60100 kg Clinically normal physical finding , medical history laboratory value . Clinically significant illness clinical relevant trauma within 2 week study start . History clinically significant heart arrythmias heart disease/problems . Previous participation PET study within past 12 month . Suffer claustrophobia would unable undergo MRI ( magnetic resonance imaging ) PET scan .</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>November 2008</verification_date>
	<keyword>Anxiety</keyword>
	<keyword>GABA receptor</keyword>
	<keyword>Positron Emission Tomography</keyword>
	<keyword>PET</keyword>
	<keyword>phase I</keyword>
</DOC>